Episodes
-
Front-Line Treatment of Chronic Lymphocytic Leukemia
October 13th, 2020 | 54 mins 19 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the first-line treatment of chronic lymphocytic leukemia with Dr John Pagel, moderated by Neil Love, MD.
-
Hodgkin Lymphoma
October 2nd, 2020 | 40 mins 59 secs
cancer, cancer treatment, chemotherapy, dr neil love, hodgkin lymphoma, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of Hodgkin lymphoma with Dr Craig Moskowitz, moderated by Neil Love, MD.
-
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition
September 30th, 2020 | 52 mins 20 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, leukemia, oncology, oncology education, research to practice
Featuring a discussion of recent data with induction and maintenance therapy for acute myeloid leukemia with Jeffrey E Lancet, MD moderated by Neil Love, MD.
-
PARP Inhibitors in Breast Cancer Edition
September 23rd, 2020 | 58 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of PARP inhibitors in breast cancer with Dr Susan Domchek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
September 21st, 2020 | 41 mins 38 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of myeloproliferative neoplasms with Dr Srdan Verstovsek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
September 17th, 2020 | 51 mins 47 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, mutations, oncology, oncology education, research to practice, telemedicine
Featuring a discussion on recent advances in the treatment of EGFR mutation-positive non-small cell lung cancer with Dr Pasi Jänne, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition
September 15th, 2020 | 42 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, multiple myeloma, oncology, oncology education, research to practice
For this special edition of Oncology Today, I met with Dr Nikhil Munshi from the Dana-Farber Cancer Institute in Boston to discuss recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma.
-
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
September 11th, 2020 | 46 mins 35 secs
bladder cancer, cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of immunotherapy for urothelial bladder cancer with Dr Petros Grivas, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition
September 4th, 2020 | 39 mins 39 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice, skin cancer
For this special edition of Oncology Today, I met with Dr Nikhil Khushalani from Moffitt Cancer Center to discuss recent data and optimal management of cutaneous squamous cell carcinoma.
-
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition
August 28th, 2020 | 45 mins 25 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer.
-
Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard
August 18th, 2020 | 1 hr 26 mins
cancer, cancer treatment, chemotherapy, dr neil love, follicular lymphoma, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion on recent data and optimal management of follicular lymphoma with Drs Carla Casulo and John P Leonard moderated by Neil Love, MD.
-
Oncology Today Special Roundtable: Colorectal Cancer
August 5th, 2020 | 1 hr 30 mins
cancer, cancer treatment, chemotherapy, colorectal cancer, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD.
-
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson
August 1st, 2020 | 15 mins 34 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.
-
Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer
June 16th, 2020 | 15 mins 13 secs
cancer, cancer treatment, chemotherapy, dr neil love, oncology, oncology education, pancreatic cancer, research to practice
Is it worthwhile to treat pancreatic cancer? Dr Michael Pishvaian from Johns Hopkins University discusses the use of the PARP inhibitor olaparib and other new developments in the disease.
-
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2
June 5th, 2020 | 27 mins 40 secs
cancer, cancer treatment, chemotherapy, chronic lymphocytic leukemia, cll, covid, covid-19, dr neil love, hematology, oncology, oncology education, research to practice, sars-cov2
Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2.
-
Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19
May 27th, 2020 | 16 mins 4 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, nurses, nursing, oncology, oncology education, oncology nurse, research to practice, telemedicine
Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care.